TIANYIN PHARMACEUTICAL CO IN COM - 88630M104

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q1 2014 · Compare: Q4 2013
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
POPE ASSET MANAGEMENT, LLC History Reduced 2,284,900 2,244 1.29% 5.65% 1 -2,872,758 -55.7% Q1 2014 May 09, 2014
RENAISSANCE TECHNOLOGIES LLC History Added to 620,100 609 0.0% 0.0% 2 +131,400 26.89% Q1 2014 May 14, 2014
KCG Holdings, Inc. History Reduced 40,039 39 0.0% 0.0% 3 -4,858 -10.82% Q1 2014 May 15, 2014
CITADEL ADVISORS LLC History Added to 39,092 38 0.0% 0.0% 4 +24,289 164.08% Q1 2014 May 15, 2014
Rotella Capital Management, Inc. History New 30,305 30 0.04% — 5 +30,305 New Q1 2014 May 21, 2014
Spark Investment Management LLC History Reduced 25,900 25 0.0% 0.01% 6 -14,800 -36.36% Q1 2014 May 13, 2014
Regent Investment Management LLC History No change 24,600 24 0.01% 0.01% 7 0 0.0% Q1 2014 Apr 14, 2014
CREDIT SUISSE AG/ History New 15,343 15 0.0% — 8 +15,343 New Q1 2014 May 15, 2014
Baltimore-Washington Financial Advisors, Inc. History No change 5,100 5 0.0% 0.0% 9 0 0.0% Q1 2014 May 01, 2014
UBS AG History Closed out 0 0 — 0.0% — -3,088 -100.0% Q1 2014 May 16, 2014